New drug combo aims to make kidney transplants safer and Longer-Lasting
Disease control
Completed
This study tested a new combination of drugs (siplizumab and belatacept) against standard care in 76 people who just received a kidney transplant. The goal was to see if the new combo is safer and helps the kidney work better. Participants took these medications for life to preve…
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC